Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Crystal Palace charged by FA over fans’ banner of Forest owner Marinakis
5/11/2025
‘Everybody comes from a place of mundanity’ : northern gothic, the strange music scene rooted in small-town Yorkshire and Lancashire
5/11/2025
Brendan Fraser and Rachel Weisz to reunite for new Mummy movie – reports
5/11/2025
Share a tip on an a winter UK rural break
5/11/2025
M&S boss says Reeves made customers more worried with pre-budget speech
5/11/2025
This machine could keep a baby alive outside the womb. How will the world decide to use it ?
5/11/2025